Vifor Pharma to Commercialize ChemoCentryx CCX168 in Several Ex-US Markets – Genetic Engineering & Biotechnology News

Vifor Pharma to Commercialize ChemoCentryx CCX168 in Several Ex-US Markets – Genetic Engineering & Biotechnology News

Vifor Pharma to Commercialize ChemoCentryx CCX168 in Several Ex-US Markets – Genetic Engineering & Biotechnology News
Published on 2016-05-10